SARS-CoV-2 vaccine development remains challenging due to high viral mutation rates associated with spike protein targeting. This study explored nucleocapsid (N) protein as an alternative immunogenic antigen using in silico approaches. The N protein sequences from three SARS-CoV-2 variants endemic to Java Island (obtai...
Subhan Nugraha, Surya Rosa Putra, Devy Maulidya Cahyani et al.· EPJ Web of Conferences· 0 citations
The SARS-CoV-2 envelope protein (protein E) is a small but multifunctional structural protein that plays a critical role in viral assembly, budding, and pathogenesis, making it an attractive target for therapeutic intervention. This study investigated the interaction between the SARS-CoV-2 envelope protein (wild type a...
Afifah Husni Riani, Surya Rosa Putra, Devy Maulidya Cahyani et al.· EPJ Web of Conferences· 0 citations
The high mutation rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) may alter viral protein structures and reduce the effectiveness of vaccines that primarily target the spike (S) protein. The nucleocapsid (N) protein is highly conserved and immunogenic, making it a promising alternative antigen for...
Wenny Maylina Mulyo Tjahyani, Surya Rosa Putra, Devy Maulidya Cahyani et al.· EPJ Web of Conferences· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.